91
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Phytochemical analysis, antiproliferative, antibacterial, antifungal, and antiviral activities of bitter orange (Citrus aurantium) leaf essential oil

, ORCID Icon, , ORCID Icon, , , & show all
Pages 408-418 | Received 02 Sep 2023, Accepted 29 Jan 2024, Published online: 23 Feb 2024
 

Abstract

The young and old leaves of bitter orange (Citrus aurantium) were examined for their essential oil (EO) compositions, anticancer, antimicrobial, and antiviral activities. The EO yields were 0.77% in young leaves and 0.26% in old leaves. The EO composition showed the predominance of sabinene (37.17%), E-β-ocimene (8.21%), δ-3-carene (7.71%), linalool (7.35%), and limonene (5.43%) in young leaves while of sabinene (47.47%), β-sinensal (5.71%), E-β-ocimene (4.98%), δ-3-carene (4.11%), and β-caryophyllene (4.06%) in old leaves. The EOs of both young and old leaves showed potent cytotoxic activities against human lung carcinoma (A549) and colon adenocarcinoma (DLD-1) cells with IC50 < 0.1 µg/mL. The young leaf EO had higher antibacterial activity than the old leaf EO for all bacterial strains with inhibition zones (IZ) varying from 17 to 45 and 8 to 36 mm, respectively. The EOs of both young and old leaves had strong antifungal activity against all fungal strains with IZ = 90 mm. The young leaf EO was found to be the most active in protecting cells against Herpes simplex virus type-1 (HSV-1) infection during the protection, absorption, and direct periods as compared to the untreated and treated Vero cells except the replication phase.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.